Recruiting Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer NCT06495125 Conditions Adenocarcinoma, Adenocarcinoma of Lung, Advanced Lung Adenocarcinoma, +13 more Locations Emory University Hospital Midtown — Atlanta, Georgia, United States Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia, United States Emory Saint Joseph's Hospital — Atlanta, Georgia, United States View Trial Details
Recruiting CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000 Conditions Adenocarcinoma, Adenocarcinoma of Lung, Adnexal Diseases, +67 more Locations Northwestern University — Chicago, Illinois, United States View Trial Details
Completed Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect NCT05204758 Conditions Advanced Lung Adenocarcinoma Locations Not specified View Trial Details
